logo
Search orAI Icon𝛼SK
ENTITY

Tsh Biopharm Corp (8432 TT)

1
Analysis
Health Care • Taiwan
TSH Biopharm Corporation Ltd.develops, manufactures and markets drugs for cadiovascular, gastrointestinal and central nervous system diseases.
more
Exchange Announcement • 08 Dec 2025 16:18

Tsh Biopharm And Zhaoke Ophthalmology Have Partnered To Introduce An Innovative Presbyopia Treatment, Bcsa25.

Exchange Announcement • 08 Dec 2025 16:17

Tsh Biopharm Was Invited To Attend The Institutional Investor Conference Hosted By Reliance Securities

Exchange Announcement • 02 Dec 2025 15:12

Announcement On Behalf Of Major Subsidiary,Chuang Yi Biotech Co., Ltd.Regarding To Change Stock Agency

Exchange Announcement • 05 Nov 2025 18:00

Tsh Board Of Directors Approved The Consolidated Financial Statements For The Nine Months Ended September 30, 2025

Exchange Announcement • 28 Oct 2025 15:58

To Announce The Expected Date Of The Board Of Directors Meeting To Approve The Consolidated Financial Statements Is 2025/11/05 For The Third Quarter Of 2025

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.61.1

x